
|Podcasts|November 3, 2017
Alzheimer Disease: New Drugs in the Offing?
Author(s)Howard Fillit, MD
What medications are in the pipeline that may help slow or even prevent the development of Alzheimer disease?
Advertisement
What medications are in the pipeline that may help slow or even prevent the development of Alzheimer disease?
Here, Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
A Clinical Review of the 2025 Neuromyelitis Optica Spectrum Disorder Guidelines
2
Phase 2 Subpopulation Data of Vidofludimus Calcium in Progressive Multiple Sclerosis: Robert J. Fox, MD
3
FDA Action Update, December 2025: Acceptance, Approval, and Clearance
4
FDA Approves Generic Glatiramer Acetate Injection for Multiple Sclerosis Treatment
5



























